Lite Strategy (LITS) Stock: Buy, Sell, or Hold?
LITS - Lite Strategy, Inc. Common Stock
$1.38
0.00 (0.36%)
▲
5d:
-4.17%
30d:
+32.69%
90d:
+41.44%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When LITS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LITS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LITS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: LITS is currently trading at $1.38, which is considered extended relative to its 30-day fair value range of $1.00 to $1.31.
Technical Outlook: Technically, LITS is in a uptrend. Immediate support is located at $1.08, while resistance sits at $1.54.
Market Sentiment: LITS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LITS is in a uptrend. Immediate support is located at $1.08, while resistance sits at $1.54.
Market Sentiment: LITS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.00 -
$1.31
Company Quality Score
31/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.9%
All Signals
- BEARISH: Price extended above range (+5.3% above its trading range)
- BEARISH: Weak technical setup (0/100)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.00 -
$1.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.08
Resistance Level
$1.54
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.62
Share & Embed Analysis
Last updated: October 03, 2026 11:52 PM ET
Data refreshes hourly during market hours. Next update: 12:52 AM
Data refreshes hourly during market hours. Next update: 12:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LITS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 46 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |